Allergan nixes women's health sale in wake of Esmya rejection

29th January 2019 Uncategorised 0

Allergan had said back in May that it would pursue a sale of its women’s health business. But at least for now, the company plans to keep the unit that analysts have said could generate $6 billion in a sale.

More: Allergan nixes women's health sale in wake of Esmya rejection
Source: fierce